- Deutz, et al. Clin Nutr. 2014;33(6);929-36
- Morris, et al. Geriatrics (Basel). 2020;5(1):6
- Bauer, et al. J Am Med Dir Assoc. 2013;14(8):542-59
- Severin, et al. Topics Geriatric Med. 2019;35(1)79-87
- Grootswagers, et al. Proc Nutr Soc. 2021;80(3):339-43
- Cawood, et al. Ageing Res. Rev 2012;11:278-96
- Cawood, et al. Ageing Res Rev, 2023, 88(101953)
- NICE Clinical Guideline 32, August 2017. Available at: www.nice.org.uk/guidance/cg32. Accessed on: 8th January 2025.
- Volkert, et al. Clin Nutr. 2022;41(1):958-89
- Stratton, et al. Managing malnutrition to improve lives and save money, October 2018. Available at: www.bapen.org.uk/pdfs/reports/mag/managing-malnutrition.pdf. Accessed on: 8th January 2025.
- Roberts, et al. Nutrients. 2019;11(4):808
ᶱ Oral Nutritional Supplements with ≥20% of energy from protein
# Based on meta-analysis compared to control.
## Based on NHS dm+d data taken in December 2024 comparing Fortisip Extra 200ml to Altraplen Protein 200ml and Fresubin Protein Energy 200ml.
### Home Usage study with N=100 patients diagnosed with Disease Related Malnutrition (2023, UK)
* p<0.001
** Control: Standard diet, +/- placebo depending on the study
*** Mean energy density of 1.5 kcal/ml and mean energy from protein 22%
^ Product can be provided to patients upon the request of a Healthcare Professional. They are intended for the purpose of professional evaluation only.
Fortisip Extra is a Food for Special Medical Purposes for the dietary management of disease related malnutrition and must be used under medical supervision.
This information is intended for healthcare professionals only.
Date of publication: January 2025.
ONS = Oral Nutritional Supplement
ESPEN = The European Society for Clinical Nutrition and Metabolism